Research progress of EZH2 in non-tumor renal diseases
The enhancer of zeste homolog 2 <italic>(EZH2</italic>) is a histone H3 lysine 27 methyltransferase, with an established role in various kidney diseases. This article reviewed the research progress of <italic>EZH2</italic> in non-tumor kidney diseases by searching and reviewi...
Saved in:
| Main Authors: | Wang Hui, Wang Ting-ting, Liu Hong-bao |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2025-05-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.05.013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The EZH2 selective inhibitor ZLD1039 attenuates UUO-induced renal fibrosis by suppressing YAP activation
by: Qingling Xia, et al.
Published: (2025-06-01) -
GGCT participates in the malignant process of hepatocellular cancer cells by regulating the PTEN/PI3K/AKT pathway through binding to EZH2
by: Junbo He, et al.
Published: (2025-02-01) -
Non-steroidal mineralocorticoid receptor antagonist finerenone inhibits peritoneal fibrosis induced by high-glucose dialysate via regulating enhancer of zeste homolog 2 (EZH2) expression
by: Dandan Chen, et al.
Published: (2025-12-01) -
Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer
by: Wen-Chi Cheng, et al.
Published: (2021-01-01) -
miR‐4448/Girdin/Akt/AMPK axis inhibits EZH2‐mediated EMT and tumorigenesis in small‐cell lung cancer
by: Nobuyuki Koyama, et al.
Published: (2024-10-01)